NeoVentures Biotechnology Inc.
PrivateLast Round
Grant
Jan 1, 2025
Total Funding Raised
$620,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeoVentures Biotechnology Inc. operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in January 2025.
NeoVentures Biotechnology Inc. is a biotechnology company that provides aptamer discovery and validation services and develops proprietary aptamer-based diagnostic and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeoVentures Biotechnology Inc. Comparables
Compare NeoVentures Biotechnology Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aptagen, LLC | 89% | |
| Raptamer Therapeutics | 86% | |
| AptaMatrix, Inc. | 85% |
For institutional investors. Book with your work email.
NeoVentures Biotechnology Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2025 | ||||
| Series A | Mar 18, 2024 | ||||
| Grant | Apr 30, 2022 | ||||
| Grant | Jun 16, 2009 | ||||
| Grant | Aug 6, 2008 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeoVentures Biotechnology Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon Europe | Grant |
| Government of Canada | Grant |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 64% MoM.
- Jun 19, 2026
Monthly visitors increased 49% MoM.
For institutional investors. Book with your work email.
NeoVentures Biotechnology Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeoVentures Biotechnology Inc.'s valuation, stock price, and market status.
Is NeoVentures Biotechnology Inc. a public or private company?
NeoVentures Biotechnology Inc. is a private company.
What is the current stock price of NeoVentures Biotechnology Inc.?
NeoVentures Biotechnology Inc. is a private company, so its shares have no public market price. Caplight tracks NeoVentures Biotechnology Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeoVentures Biotechnology Inc. worth (valuation)?
Valuation information for NeoVentures Biotechnology Inc. is not publicly available.
Can I buy NeoVentures Biotechnology Inc. stock?
NeoVentures Biotechnology Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeoVentures Biotechnology Inc.'s last funding round?
NeoVentures Biotechnology Inc.'s most recent funding round was Grant on January 1, 2025.
Who are the main investors in NeoVentures Biotechnology Inc.?
Key investors in NeoVentures Biotechnology Inc. include Horizon Europe, Government of Canada, Alzheimer's Drug Discovery Foundation.
Will NeoVentures Biotechnology Inc. IPO soon?
No public IPO plans have been announced for NeoVentures Biotechnology Inc..
How can I track NeoVentures Biotechnology Inc. secondary market activity?
Caplight tracks bids, offers, and trades in NeoVentures Biotechnology Inc.'s shares on secondary markets.